Crossmark

Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan

Crossref DOI link: https://doi.org/10.1007/s10147-019-01456-4

Published Online: 2019-05-04

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nomura, Hidetaka

Sekine, Masayuki

Yokoyama, Shiro

Arai, Masami

Enomoto, Takayuki

Takeshima, Nobuhiro

Nakamura, Seigo
License Information

Text and Data Mining valid from 2019-05-04
More Information

Article History

Received: 22 October 2018

Accepted: 23 April 2019

First Online: 4 May 2019

Compliance with ethical standards

:

: Dr. Seigo Nakamura received an honoraria for a seminar presentation from AstraZeneca. Dr. Takayuki Enomoto received an honoraria for lecture fees from Chugai Pharm. Dr. Masayuki Sekine received an honoraria for lecture fees from AstraZeneca. The other authors declare no conflicts of interest.